Xiang Shu

Dr., Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center
Contributors
United States of America

About Xiang Shu

Dr. Shu’s research primarily focuses on identifying novel genetic and molecular markers for cancer risk, with the goal of better understanding tumorigenesis and providing novel tools for risk assessment.

Areas of Expertise

Research

Subject Areas

Health sciences

New MR study reveals heterogeneity of circulating proteins in association with risk of breast cancer subtypes

The etiologic role of circulating proteins in development of breast cancer subtypes is not clear. We aimed to examine the potential causal effects of circulating proteins on risk of breast cancer by intrinsic-like subtypes within the Mendelian randomization (MR) framework.